Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |